Cc1ccc(NC(=O)Cc2ccc(-n3c(C)nc4cccnc43)cc2)cc1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?